Neoplasm of Lung

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-12-05
Clinical Trial Update: CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab [Phase 1, Phase 2]
Phase 1/2 trial of CD40 agonist APX005M (sotigalimab) with nivolumab in cancer including metastatic non-small cell lung cancer and melanoma …